Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers

Prevalence and clinical significance of occult hepatitis B virus infection among renal transplant recipients in Korea

(2012) Eunsin Bae et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Impact of Pre-Existing Hepatitis B Infection on the Outcomes of Kidney Transplant Recipients in the United States

(2011) P. N. Reddy et al.   Clinical Journal of the American Society of Nephrology

Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues

(2011) Nancy Leung   LIVER INTERNATIONAL

Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B

(2011) P. Lampertico et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Antiviral resistance and hepatitis B therapy

(2010) Marc G. Ghany et al.   HEPATOLOGY

Hepatitis B virus infection and related factors in hemodialysis patients in China – systematic review and meta-analysis

(2010) Cuiyu Wang et al.   RENAL FAILURE

Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier

(2009) N. Fukushima et al.   ANNALS OF ONCOLOGY

Lamivudine for chronic hepatitis B: a brief review

(2009) Emilio Palumbo   Brazilian Journal of Infectious Diseases

Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B

(2009) Kai Chung Tse et al.   CLINICAL TRANSPLANTATION

Hepatitis B Virus Infection and the Dialysis Patient

(2008) Fabrizio Fabrizi et al.   SEMINARS IN DIALYSIS